Additionally, in several intrinsic molecular subtypes of breast cancer, heightened expression of YTHDF3 is accompanied by increased patient mortality rates, suggesting its importance as an oncogene in breast cancer and its selection during the cancer evolution process. The gene discussed is YTHDF3; the disease is cancer.